Glenview Capital Management, LLC filed Q1 2026 13F: CVS leads a $4B portfolio

Filed: 2026-05-15 · Report date: 2026-03-31 · Form: 13F-HR

Source: SEC EDGAR filing

Portfolio overview

Portfolio value: $4B
Holdings: 44
Previous quarter: 2025-12-31

Top 5 holdings

CVS — $588.7M (14.8%)
GLOBAL PMTS INC — $428.1M (10.7%)
THC — $287.8M (7.2%)
AMZN — $220.6M (5.5%)
TEVA PHARMACEUTICAL INDS LTD — $200.6M (5.0%)

New positions

QQQ — $189.4M (4.8%)
IWM — $93M (2.3%)
HUM — $58.1M (1.5%)
CSCO — $26.4M (0.66%)
BKR — $18.5M (0.47%)

Exits

HYG — last seen at $142.9M
EXPEDIA GROUP INC — last seen at $91.1M
KNX — last seen at $76.3M
TLT — last seen at $54.5M
ACN — last seen at $51.3M

Biggest adds

META — +$62.5M (now $70.2M)
CI — +$56.2M (now $133.1M)
AMD — +$48M (now $132.4M)

Biggest trims

GLOBAL PMTS INC — -$451.6M (now $6.7M)
TEVA PHARMACEUTICAL INDS LTD — -$321.2M (now $200.6M)
GTM — -$108.3M (now $95.1M)

Methodology note

13F filings are public quarterly disclosures with up to a 45-day lag from quarter-end. Numbers here reflect the manager's disclosed long US equity positions only; they are not a real-time portfolio, do not include derivatives or short positions, and are not actual fund NAV. Not investment advice.

Full case file: https://worldsmartmoney.com/manager/glenview

This article: https://worldsmartmoney.com/news/glenview-2026-03-31-002354

English thread

Tweet 1/5 · 167 chars

Glenview Capital Management, LLC filed Q1 2026 13F.

Portfolio: $4B (44 holdings)
Top: CVS $588.7M (14.8%)

https://worldsmartmoney.com/news/glenview-2026-03-31-002354

Tweet 2/5 · 166 chars

Top 5 holdings:

1. CVS $588.7M (14.8%)
2. GLOBAL PMTS INC $428.1M (10.7%)
3. THC $287.8M (7.2%)
4. AMZN $220.6M (5.5%)
5. TEVA PHARMACEUTICAL INDS LTD $200.6M (5.0%)

Tweet 3/5 · 106 chars

Position changes from 2025-12-31:

🆕 New: QQQ, IWM, HUM, CSCO
🚪 Exited: HYG, EXPEDIA GROUP INC, KNX, TLT

Tweet 4/5 · 157 chars

📈 Biggest adds:
  META +$62.5M
  CI +$56.2M
  AMD +$48M

📉 Biggest trims:
  GLOBAL PMTS INC -$451.6M
  TEVA PHARMACEUTICAL INDS LTD -$321.2M
  GTM -$108.3M

Tweet 5/5 · 239 chars

Source: SEC 13F (≤45-day disclosure lag, not real-time, not fund NAV).

SEC: https://www.sec.gov/Archives/edgar/data/1138995/000090514826002354/0000905148-26-002354-index.htm
WSM: https://worldsmartmoney.com/news/glenview-2026-03-31-002354

Chinese thread

Tweet 1/5 · 148 chars

Glenview Capital Management, LLC 更新 2026 Q1 13F

组合：$4B（44 只持仓）
第一持仓：CVS $588.7M（14.8%）

https://worldsmartmoney.com/news/glenview-2026-03-31-002354

Tweet 2/5 · 154 chars

前 5 大持仓：

1. CVS $588.7M（14.8%）
2. GLOBAL PMTS INC $428.1M（10.7%）
3. THC $287.8M（7.2%）
4. AMZN $220.6M（5.5%）
5. TEVA PHARMACEUTICAL INDS LTD $200.6M（5.0%）

Tweet 3/5 · 79 chars

相比 2025-12-31 的变化：

🆕 新建仓：QQQ、IWM、HUM、CSCO
🚪 清仓：HYG、EXPEDIA GROUP INC、KNX、TLT

Tweet 4/5 · 140 chars

📈 加仓最多：
  META +$62.5M
  CI +$56.2M
  AMD +$48M

📉 减仓最多：
  GLOBAL PMTS INC -$451.6M
  TEVA PHARMACEUTICAL INDS LTD -$321.2M
  GTM -$108.3M

Tweet 5/5 · 208 chars

来源：SEC 13F（最多滞后 45 天公开，非实时，不代表基金净值）

SEC 原文：https://www.sec.gov/Archives/edgar/data/1138995/000090514826002354/0000905148-26-002354-index.htm
WSM 解读：https://worldsmartmoney.com/news/glenview-2026-03-31-002354

13F is a quarterly disclosure with up to 45-day lag. Not real-time, not fund NAV, not investment advice.